Clinical trial
Insulin Glargine Vs Standard Insulin Therapy
NCT00222521 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00222521 |
|---|---|
| Title | Insulin Glargine Vs Standard Insulin Therapy |
| Official title | Comparison of Insulin Glargine Vs Standard Insulin Therapy in CFRD Without Fasting Hyperglycemia |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | Sanofi Industry Moran, Antoinette, M.D. |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis Related Diabetes |
| Intervention type | Drug |
| Interventions | Glargine insulin |
| Enrollment | 20 |
| Start date | Apr 1, 2003 |
| Completion | Aug 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: